Learning from the crisis
The Covid-19 pandemic shaped myriad aspects of 2021, as it had in 2020. An analysis of the knowledge gained in 2020 led to the introduction of changes in both the blood and the blood stem cell fields. The focus in this respect was always on donor and patient safety and the mission of ensuring the continuous availability of blood products.
Swiss Transfusion SRC is an autonomous organisation within the Swiss Red Cross, structured as a non-profit-making company limited by shares (gemeinnützige Aktiengesellschaft). The majority of its shares are owned by the SRC; the eleven regional blood transfusion services hold the remaining shares. Swiss Transfusion SRC is – together with the regional blood transfusion services – responsible for managing the blood supply on behalf of the SRC and holds a mandate from the Swiss Government to manage the registry of blood stem cell donors. No funding is provided for expanding the registry, however. Swiss Transfusion SRC has to rely on monetary donations to meet those costs.